Trial reportThe Journal of urology2024
Prophylactic Use of Biologic Mesh in Ileal Conduit (PUBMIC): A Randomized Clinical Trial.
Trial report in The Journal of urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02439060 (Prevention of Parastomal Hernia Following Radical Cystectomy and Ileal Conduit Using Biologic Mesh), which is not on this map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Prevention of Parastomal Hernia Following Radical Cystectomy and Ileal Conduit Using Biologic Mesh: Randomized Clinical Trial
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Parastomal hernia after robot-assisted cystectomy and ileum conduit: incidence, risk or protective factors and outcomes of minimal-invasive hernia repair-systematic review.Journal of robotic surgery · 2026Pooled it
- Preventing Parastomal Hernias After Radical Cystectomy with Ileal Conduit: A Systematic Review Regarding Surgical Prophylactic Techniques.Journal of personalized medicine · 2026Review
- Prevention of parastomal hernia after ileal conduit using prophylactic mesh: A meta-analysis of randomized controlled trials.Arab journal of urology · 2026Review
- Efficacy of prophylactic use of biologic mesh in ileal conduit: insights from the PUBMIC trial.Translational andrology and urology · 2025Article
- Accounting for the learning curve effect in surgical trials: Post-hoc analysis of the prophylactic use of biologic mesh in ileal conduit (PUBMIC) trial.Investigative and clinical urology · 2025Article
- Prophylactic mesh placement is not sufficient: what should we do to prevent parastomal hernia associated with ileal conduit?Translational andrology and urology · 2025Article
- Utility of prophylactic mesh in the prevention of parastomal hernia after ileal conduit: assessing the current evidence.Translational andrology and urology · 2025Article
- Prophylactic Use of Biologic Mesh in Ileal Conduit (PUBMIC trial).Translational andrology and urology · 2025Article
- Comment to: Initial and recurrent management of parastomal hernia after cystectomy and ileal conduit urinary diversion.Hernia : the journal of hernias and abdominal wall surgery · 2025Article
- Prophylactic Mesh in Parastomal Hernia Prevention: Current Evidence.Journal of abdominal wall surgery : JAWS · 2025Review
- Round up.Indian journal of urology : IJU : journal of the Urological Society of IndiaArticle
- Early postoperative outcomes of intraperitoneal funnel mesh for parastomal hernia prevention in robotic radical cystectomy: A retrospective feasibility study.Indian journal of urology : IJU : journal of the Urological Society of IndiaArticle
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe assessed the effect of prophylactic biologic mesh on parastomal hernia (PSH) development in patients undergoing cystectomy and ileal conduit (IC). MATERIALS AND
methodsThis phase 3, randomized, controlled trial (NCT02439060) included 146 patients who underwent cystectomy and IC at the University of Southern California between 2015 and 2021. Follow-ups were physical exam and CT every 4 to 6 months up to 2 years. Patients were randomized 1:1 to receive FlexHD prophylactic biological mesh using sublay intraperitoneal technique vs standard IC. The primary end point was time to radiological PSH, and secondary outcomes included clinical PSH with/without surgical intervention and mesh-related complications.
resultsThe 2 arms were similar in terms of baseline clinical features. All surgeries and mesh placements were performed without any intraoperative complications. Median operative time was 31 minutes longer in patients who received mesh, yet with no statistically significant difference (363 vs 332 minutes,
conclusionsImplementation of biologic mesh at the time of IC construction is safe without significant protective effects within 2 years following surgery.
Indexed as
Identifiers
38620056What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.